Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    June 2017
  1. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    March 2017
  2. TRIMARCHI H, Barratt J, Cattran DC, Cook HT, et al
    Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA Nephropathy Classification Working Group.
    Kidney Int. 2017 Mar 21. pii: S0085-2538(17)30101.
    PubMed     Text format     Abstract available


  3. ROSENZWAJG M, Languille E, Debiec H, Hygino J, et al
    B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30039.
    PubMed     Text format     Abstract available


    January 2017
  4. LUQUE Y, Cathelin D, Vandermeersch S, Xu X, et al
    Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Kidney Int. 2017 Jan 19. pii: S0085-2538(16)30653.
    PubMed     Text format     Abstract available


  5. CATTRAN DC, Brenchley PE
    Membranous nephropathy: integrating basic science into improved clinical management.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30617.
    PubMed     Text format     Abstract available


    November 2016
  6. BELLUR SS, Lepeytre F, Vorobyeva O, Troyanov S, et al
    Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30562.
    PubMed     Text format     Abstract available


  7. YAN JJ, Lee JG, Jang JY, Koo TY, et al
    IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30551.
    PubMed     Text format     Abstract available


  8. COSIO FG, Cattran DC
    Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation.
    Kidney Int. 2016 Nov 9. pii: S0085-2538(16)30484.
    PubMed     Text format     Abstract available


    October 2016
  9. PANG Y, Tan Y, Li Y, Zhang J, et al
    Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Kidney Int. 2016 Oct 10. pii: S0085-2538(16)30437.
    PubMed     Text format     Abstract available


  10. CATTRAN DC
    Toward quantitating the burden of glomerulonephritis in the United States.
    Kidney Int. 2016;90:732-4.
    PubMed     Text format     Abstract available


    August 2016
  11. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Text format     Abstract available


  12. LEVENTHAL JS, Ross MJ
    LAPping up dead cells to prevent lupus nephritis: a novel role for noncanonical autophagy in autoimmunity.
    Kidney Int. 2016;90:238-9.
    PubMed     Text format     Abstract available


    July 2016
  13. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


  14. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.
    PubMed     Text format    


  15. ANDERS HJ, Rovin B
    A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
    Kidney Int. 2016 Jul 1. pii: S0085-2538(16)30208.
    PubMed     Text format     Abstract available


    June 2016
  16. HOOVER PJ, Costenbader KH
    Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30171.
    PubMed     Text format     Abstract available


  17. RYAN MS, Satoskar AA, Nadasdy GM, Brodsky SV, et al
    Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis.
    Kidney Int. 2016;89:1402-3.
    PubMed     Text format    


  18. RAMACHANDRAN R, Kumar V, Jha V
    Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
    Kidney Int. 2016;89:1401-2.
    PubMed     Text format    


  19. GUERRY MJ, Vanhille P, Ronco P, Debiec H, et al
    Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
    Kidney Int. 2016;89:1399.
    PubMed     Text format    


    May 2016
  20. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Text format     Abstract available


  21. HOFSTRA JM, Wetzels JF
    Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
    Kidney Int. 2016;89:981-3.
    PubMed     Text format     Abstract available


    April 2016
  22. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


  23. PICCOLI GB, Capobianco M, Vigotti FN, Naretto C, et al
    The Case | The young philosopher with multiple sclerosis and proteinuria.
    Kidney Int. 2016;89:961-3.
    PubMed     Text format    


  24. NEVES PD, Bezerra KS, Silveira MA, Yu L, et al
    Schistosoma mansoni and membranous nephropathy.
    Kidney Int. 2016;89:959.
    PubMed     Text format    


  25. ROSALES IA, Colvin RB
    Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical.
    Kidney Int. 2016;89:750-2.
    PubMed     Text format     Abstract available


  26. NASR SH, Collins AB, Alexander MP, Schraith DF, et al
    The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.
    Kidney Int. 2016;89:897-908.
    PubMed     Text format     Abstract available


    February 2016
  27. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    PubMed     Text format     Abstract available


  28. NOWAK N, Skupien J, Niewczas MA, Yamanouchi M, et al
    Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.
    Kidney Int. 2016;89:459-67.
    PubMed     Text format     Abstract available


    January 2016
  29. PRUTHI R, McClure M, Casula A, Roderick PJ, et al
    Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis.
    Kidney Int. 2016 Jan 21. pii: S0085-2538(15)00176.
    PubMed     Text format     Abstract available


  30. HOUSSIAU FA
    Moving East: the Euro-Lupus Nephritis regimen in Asia.
    Kidney Int. 2016;89:25-7.
    PubMed     Text format     Abstract available


  31. FLOEGE J
    Prognostic assessment of IgA nephropathy: how much does histology add?
    Kidney Int. 2016;89:19-21.
    PubMed     Text format     Abstract available


  32. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    PubMed     Text format     Abstract available


  33. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    PubMed     Text format     Abstract available


  34. KLUGER MA, Melderis S, Nosko A, Goerke B, et al
    Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
    Kidney Int. 2016;89:158-66.
    PubMed     Text format     Abstract available


  35. IRIFUKU T, Doi S, Sasaki K, Doi T, et al
    Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
    Kidney Int. 2016;89:147-57.
    PubMed     Text format     Abstract available


  36. SELEZNIK G, Seeger H, Bauer J, Fu K, et al
    The lymphotoxin beta receptor is a potential therapeutic target in renal inflammation.
    Kidney Int. 2016;89:113-26.
    PubMed     Text format     Abstract available


    December 2015
  37. SETHI S, Fervenza FC, Smith RJ, Haas M, et al
    Overlap of ultrastructural findings in C3 glomerulonephritis and dense deposit disease.
    Kidney Int. 2015;88:1449-1450.
    PubMed     Text format    


    November 2015
  38. SERINO G, Pesce F, Sallustio F, De Palma G, et al
    In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.
    Kidney Int. 2015 Nov 18. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  39. RAMACHANDRAN R, Kumar V, Nada R, Jha V, et al
    Serial monitoring of anti-PLAR in initial PLAR-negative patients with primary membranous nephropathy.
    Kidney Int. 2015;88:1198-1199.
    PubMed     Text format    


  40. COUSER WG, Johnson RJ
    What is myeloperoxidase doing in ANCA-associated glomerulonephritis?
    Kidney Int. 2015;88:938-940.
    PubMed     Text format     Abstract available


    April 2015
  41. CROFT AP, Smith SW, Carr S, Youssouf S, et al
    Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis.
    Kidney Int. 2015;87:807-11.
    PubMed     Text format     Abstract available


    March 2015
  42. SCHREIBER A, Schindler R, Adcock Funk DM, Kahl A, et al
    The Case | A 48-year-old man with pulmonary-renal syndrome.
    Kidney Int. 2015;87:667-8.
    PubMed     Text format    


  43. SPINALE JM, Mariani LH, Kapoor S, Zhang J, et al
    A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Kidney Int. 2015;87:564-74.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: